President Donald Trump's order to for pharmaceutical companies to cut drug prices received mixed reactions, with some members ...

Experts said the president's executive order could work in lowering costs, but it won't make for an immediate fix.

The order is expected to impact innovator companies, which may spend less on research in an effort to cut costs, analysts ...

Despite recent stock corrections, Piramal Pharma has shown remarkable resilience, tripling investor wealth since 2023-24.

Reform how pharmacy benefit managers operate.

It is not surprising that President Trump issued a May 12, 2025 executive order, “Delivering Most-Favored-Nation Prescription ...

President Trump signs an executive order aimed at lowering drug prices, prompting discussions about Big Pharma's potential ...

A federal district court ruled in favor of the Health Resources and Services Administration, but raised questions about ...

From prices to tariffs to dealmaking, Trump’s involvement in economic issues prompts both frustration and applause.

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Could President Trump's proposed price cuts for prescription drugs aggravate U.S. drug shortages? We asked Seeking Alpha ...

Letters published May 13-19, 2025, deal with research funding, drug prices and what God says about diversity and dignity.